New oncology CME unit, medical director for Fission

Share this article:
Medical education company Fission Communications has created a new oncology division for clients developing new therapies to cure cancer, the company announced this week.
"We were responding to a specific need of our current client base," said Mario Nacinovich Jr., senior vice president, business development, editorial and strategic planning.
The new division, named Fission Oncology, will work with pharma companies to keep health care providers informed and educated on the newest tools in the treatment of
cancer, he said.
Fission Communications has also added Peter Mirabile as its medical director.
In his new role, Mirabile will provide medical guidance for Fission accounts, a company statement said.
Prior to joining Fission, Mirabile participated in clinical clerkships in the
U.K. and was a former consultant to law firm Chadbourne & Parke, litigation product liability tobacco cases and domestic narcotic pharmaceutical defense strategies.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.